Patents Assigned to KANGMA-HEALTHCODE (SHANGHAI) BIOTECH CO., LTD.
  • Patent number: 11946084
    Abstract: Provided are a fusion protein comprising a Pab1 element and an eIF4G element and a preparation method therefor. The fusion protein can improve in-vitro translation efficiency. A constitutive or inducible promoter (for example, pKlPGK1) may also be inserted in front of eIF4G in the fusion protein for increasing in-vitro protein synthesis ability.
    Type: Grant
    Filed: December 13, 2017
    Date of Patent: April 2, 2024
    Assignee: KANGMA-HEALTHCODE (SHANGHAI) BIOTECH CO., LTD
    Inventors: Min Guo, Shuailong Liu, Xue Yu
  • Publication number: 20220372196
    Abstract: A biomagnetic microsphere and a preparation method and a method for protein isolation and purification therefor. The outer surface of a magnetic microsphere body of the biomagnetic microsphere has at least one liner polymer with a branched chain; one end of the linear polymer with a branched chain is covalently coupled to the outer surface of the magnetic microsphere body, and other parts are free on the outer surface of the magnetic microsphere body; a backbone of the linear polymer is a polyolefin backbone, and no cross-linking agent is required in the backbone forming process of the linear polymer. The prepared biomagnetic microsphere can implement efficient elution of target proteins and effectively reduce the retention time and retention ratio of the target proteins, and it is easy to operate and widely used.
    Type: Application
    Filed: June 19, 2020
    Publication date: November 24, 2022
    Applicant: KANGMA-HEALTHCODE (SHANGHAI) BIOTECH CO., LTD.
    Inventors: Min GUO, Liang WU, Liqiong XU, Zheng ZHANG, Jie SU, Xue YU
  • Publication number: 20210214693
    Abstract: Provided are an ADH protein mutant and the use thereof. Compared with a wild-type ADH protein, the mutant is capable of (i) enhancing the expression purity, efficiency and yield of exogenous proteins in an in-vitro cell-free synthesis system; and/or (ii) reducing the binding ability of the mutant protein to Ni medium.
    Type: Application
    Filed: May 28, 2019
    Publication date: July 15, 2021
    Applicant: KANGMA-HEALTHCODE (SHANGHAI) BIOTECH CO., LTD.
    Inventors: Min Guo, Mini Deng, Xue Yu